Ignite Creation Date:
2024-05-05 @ 11:30 PM
Last Modification Date:
2024-10-26 @ 10:34 AM
Study NCT ID:
NCT01345253
Status:
COMPLETED
Last Update Posted:
2019-10-04
First Post:
2011-04-28
Brief Title:
GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus SLE Located in Northeast Asia
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2015-09-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-21
Completion Date Type:
ACTUAL
First Submit Date:
2011-04-28
First Submit QC Date:
April 28 2011
Study First Post Date:
2011-05-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2016-12-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-20
Last Update Post Date:
2019-10-04
Last Update Post Date Type:
ACTUAL